Teruhiko Sakai
Direttore/Membro del Consiglio presso Junten Bio Co. Ltd.
Provenienza dei contatti di primo grado di Teruhiko Sakai
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Junten Bio Co. Ltd.
 Junten Bio Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Junten Bio Co. Ltd. is a Japanese company founded in 2018 that engages in research and development of cell and regenerative medicines. The company is based in Chuo-ku, Japan.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Teruhiko Sakai tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| KIDSWELL BIO CORPORATION | Biotechnology | President Director/Board Member | |
| IMMUNO-BIOLOGICAL LABORATORIES CO., LTD. | Medical Specialties | Director/Board Member | |
| Okayama University | College/University | Undergraduate Degree | |
| NOILE-IMMUNE BIOTECH INC. | Pharmaceuticals: Major | Director/Board Member | |
DCI Partners KK
 DCI Partners KK Investment ManagersFinance DCI Partners KK (DCI Partners) is a venture arm of Daiwa Corporate Investment Co., Ltd. founded in 2014. The firm is headquartered in Tokyo, Japan. | Investment Managers | Director/Board Member | |
REGiMMUNE Corp.
 REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
| University of Tsukuba | College/University | Graduate Degree | |
| Tokyo University of Science | College/University | Graduate Degree |
Statistiche
Distribuzione geografica
| Giappone | 9 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
| Finance | 2 |
Posizioni
| Director/Board Member | 11 |
| President | 2 |
| Graduate Degree | 2 |
| Chairman | 1 |
| Undergraduate Degree | 1 |
Contatti più connessi
- Borsa valori
- Insiders
- Teruhiko Sakai
- Connessioni Società
